Impaired Dihydrotestosterone Catabolism in Human Prostate Cancer: Critical Role of AKR1C2 as a Pre-Receptor Regulator of Androgen Receptor Signaling

2007 ◽  
Vol 67 (3) ◽  
pp. 1361-1369 ◽  
Author(s):  
Qing Ji ◽  
Lilly Chang ◽  
Frank Z. Stanczyk ◽  
Murad Ookhtens ◽  
Andy Sherrod ◽  
...  
The Prostate ◽  
2009 ◽  
Vol 70 (1) ◽  
pp. 90-99 ◽  
Author(s):  
Donald J. Vander Griend ◽  
Jason D'Antonio ◽  
Bora Gurel ◽  
Lizamma Antony ◽  
Angelo M. DeMarzo ◽  
...  

2010 ◽  
Vol 49 (10) ◽  
pp. 902-912 ◽  
Author(s):  
Gagan Deep ◽  
Subhash C. Gangar ◽  
Nicholas H. Oberlies ◽  
David J. Kroll ◽  
Rajesh Agarwal

2019 ◽  
Vol 20 (9) ◽  
pp. 2066 ◽  
Author(s):  
Namrata Khurana ◽  
Suresh C. Sikka

Androgen receptor (AR) signaling plays a key role not only in the initiation of prostate cancer (PCa) but also in its transition to aggressive and invasive castration-resistant prostate cancer (CRPC). However, the crosstalk of AR with other signaling pathways contributes significantly to the emergence and growth of CRPC. Wnt/β-catenin signaling facilitates ductal morphogenesis in fetal prostate and its anomalous expression has been linked with PCa. β-catenin has also been reported to form complex with AR and thus augment AR signaling in PCa. The transcription factor SOX9 has been shown to be the driving force of aggressive and invasive PCa cells and regulate AR expression in PCa cells. Furthermore, SOX9 has also been shown to propel PCa by the reactivation of Wnt/β-catenin signaling. In this review, we discuss the critical role of SOX9/AR/Wnt/β-catenin signaling axis in the development and progression of CRPC. The phytochemicals like sulforaphane and curcumin that can concurrently target SOX9, AR and Wnt/β-catenin signaling pathways in PCa may thus be beneficial in the chemoprevention of PCa.


Sign in / Sign up

Export Citation Format

Share Document